Furthermore, downstream activation of AKT and ERK by HGF was apparently not affected by abemaciclib, suggesting that a different compensatory mechanism might exist in the HGF-rich tumor microenvironment, and might play a prominent role in hepatic metastasis. The gene discussed is AKT1; the disease is neoplasm.